By Delilah Alvarado | BioPharma Dive August 31, 2026 In a landmark decision that promises to reshape...
Treatment Innovations
The landscape of interventional cardiology is witnessing a potential paradigm shift following the unveiling of data from...
For decades, the Electronic Health Record (EHR) has served as the digital ledger of modern medicine. While...
In the high-stakes world of cardiovascular medicine, the ability to accurately distinguish between benign plaque buildup and...
Cardiovascular disease (CVD) has long been categorized as the world’s most formidable silent killer. Responsible for an...
In a landmark shift for infectious disease management, AbbVie’s direct-acting antiviral (DAA) therapy, Maviret (glecaprevir/pibrentasvir), has secured...
In the high-stakes arena of neurotechnology and cellular research, the quest for clarity is perpetual. Every micron...
The Department of Health and Human Services (HHS) has officially opened the floor for nominations to the...
In an era where precision medicine is becoming the standard, the physical infrastructure of healthcare—specifically the delivery...
By Jacob Bell Published August 28, 2026 The biotechnology sector, often characterized by its volatile boom-and-bust cycles,...
